CroíValve wins FDA IDE for tricuspid heart valve
January 25, 2024
CroíValve announced today that it began an early feasibility study for its Duo tricuspid coaptation valve system.
CroíValve announced today that it began an early feasibility study for its Duo tricuspid coaptation valve system.
Abbott (NYSE: ABT)+
announced today that it received approval from the FDA for the launch of its Liberta RC DBS system
Siemens Healthineers announced that the FDA cleared its Syngo Virtual Cockpit, a private, secure communication platform.
Intuitive Surgical (Nasdaq: ISRG)+
announced today that it received CE mark approval for its da Vinci SP surgical robot platform.
DSMBi rates DSR 2.0 as safe following review of data from non-randomized cohort
Data from non-randomized cohort confirms dramatic improvement in diuretic response and at least 95% reduction in loop diuretic requirements up to almost four months after last DSR therapy
First patient enrolled in randomized controlled cohort expected in Q1 2024
SnoreLessNow announced today that the FDA granted 510(k) clearance for its over-the-counter dental device.
Kallisio recently announced that the FDA has cleared its 3D-printed Stentra, used to protect head and neck cancer patient’s healthy tissue during radiation therapy.
Thirona announced today that it received FDA 510(k) clearance for the latest update of its AI-based LunQ clinical software.
Pi-Cardia announced today that the FDA granted breakthrough device designation for its ShortCut leaflet modification device.
Short, toxic RNAs kill brain cells and may allow Alzheimer’s to develop